Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12"	Q8N2K0	20	25294743-25390983	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease mutation, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA					"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	11.3	13.4	27.4	10.0	32.1	9.8	10.4	22.3	39.8	11.1	15.6	30.8	14.1	20.7	9.1	58.9	20.4	11.3	14.0	12.2	41.5	25.9	18.9	13.1	14.0	10.3	31.5	21.0	13.8	65.6	16.0	14.4	25.6	26.9	15.6	15.2	11.5	13.8	17.4	4.0	16.2	21.1	9.9	43.3	7.8	22.1	7.6	19.0	10.2	36.8	7.9	16.0	15.7	10.9	3.9	14.6	12.6	14.2	11.1	11.5	6.0	14.9	34.2	8.8	11.1	18.1	10.8	21.8	21.5	18.0	16.9	19.5	20.0	22.9	4.7	12.2	16.9	40.3	24.3	11.2	12.8	14.4	4.9	9.0	7.6	9.4	27.7	14.4	7.3	16.2	13.5	8.4	20.8	9.9	20.6	7.7	8.8	5.5	71.7	16.0	30.9	11.0	7.7	6.8	18.5	21.7	8.5	22.7	44.7	11.4	31.1	11.3	9.5	18.1	44.7	31.8	16.4	15.1	12.5	9.6	21.4	14.5	13.0	12.4	8.4	7.8	7.5	14.9	8.7	13.7	9.8	14.2	12.6	8.0	12.2	6.4	3.1	8.8	11.5	14.6	3.9	7.5	7.4	1.8	11.1	13.1	13.1	7.9	6.0	27.4	32.1	22.3	39.8	41.5	25.9	31.5	21.0	26.9	19.0	6.0	6.2	9.7	26.7	15.8	33.4	14.0	38.2	10.7	9.1	26.2	9.8	77.6	23.2	30.2	42.1	13.8	92.3	0.0	29.7	81.1	22.7	35.8	10.3	16.1	103.4	39.7	32.6	11.6	27.2	80.7	15.0	39.8	32.1	91.0	27.6	27.0	20.7	45.6	19.4	19.5	20.6	25.8	14.6	18.2	32.5	15.9	109.4	13.8	31.4	31.0
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6"	Q9BV23	3	58237506-58295693	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	8.3	10.0	11.6	4.6	14.0	1.0	5.8	17.7	22.5	3.7	8.1	30.0	10.3	26.3	4.7	10.8	4.8	6.9	4.4	4.1	19.0	9.2	24.3	43.4	6.3	5.2	18.6	12.2	4.1	2.4	4.8	15.2	4.8	19.0	4.4	8.1	10.5	3.0	12.9	3.1	17.2	33.5	6.8	24.0	22.8	9.0	3.1	14.3	2.0	6.6	2.1	5.4	4.6	4.1	3.9	7.0	2.1	9.3	0.7	2.6	1.1	2.0	7.7	1.1	5.0	14.5	2.6	13.4	5.4	4.8	5.7	7.7	4.0	2.8	3.9	0.5	2.9	17.6	6.0	5.2	2.4	5.1	6.6	2.6	3.3	5.2	5.5	4.9	1.0	17.6	2.5	11.1	5.2	2.5	6.7	3.2	6.5	3.9	9.0	4.6	1.5	6.7	0.4	3.7	16.7	17.0	2.5	2.3	8.7	8.7	2.8	6.7	2.7	5.9	3.3	11.1	2.3	2.2	2.7	3.4	4.1	4.5	10.1	6.4	2.6	7.6	0.1	10.5	9.9	5.6	0.0	2.8	2.1	2.1	9.3	2.0	3.9	1.2	2.6	4.6	3.0	1.2	1.5	0.0	0.7	6.2	7.0	1.4	1.1	11.6	14.0	17.7	22.5	19.0	9.2	18.6	12.2	19.0	14.3	0.0	2.6	8.8	2.6	7.7	13.8	4.8	0.0	17.4	5.7	3.5	3.9	2.2	1.7	2.9	0.8	7.8	13.6	0.0	1.6	0.4	2.1	1.3	10.5	53.3	8.1	14.3	0.0	26.4	14.6	0.4	6.4	9.6	3.3	14.4	2.2	10.8	1.6	0.0	7.8	15.4	3.0	0.0	3.5	0.5	2.3	21.5	0.5	3.2	4.5	2.0
BSCL2	"GNG3LG, SPG17"	ENSG00000168000	"BSCL2, seipin lipid droplet biogenesis associated"	Q96G97	11	62690275-62709845	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"		"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 36.1;Early spermatids: 21.4;Late spermatids: 39.0;Spermatocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.0;Karpas-707: 61.7;RPMI-8226: 42.5;SCLC-21H: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042394	Approved					NA	NA					"HPA042394: AB_10794047"	"unprognostic (7.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.96e-1)"	6.6	41.6	38.5	3.8	66.3	5.4	13.6	41.0	65.7	20.3	10.6	11.8	13.9	5.4	10.2	77.4	7.6	31.8	11.3	4.7	39.0	81.3	19.0	10.4	11.5	6.6	34.8	27.2	14.1	36.8	35.9	61.0	6.2	32.8	14.2	7.3	12.0	31.1	17.0	6.8	8.8	4.4	7.5	13.2	5.0	10.5	59.5	10.1	9.4	17.2	4.8	5.8	8.9	7.3	19.5	30.8	19.8	33.7	22.1	18.9	25.0	4.1	15.2	10.7	20.6	36.0	12.4	1.8	1.7	9.2	3.5	3.7	2.3	6.4	2.9	3.7	6.6	2.9	14.9	1.3	5.3	1.8	7.1	1.1	2.5	8.7	1.9	7.3	2.2	3.3	8.2	4.3	7.0	2.8	5.3	2.7	8.7	1.8	61.7	5.4	10.7	2.7	5.0	32.1	3.1	2.9	5.1	1.0	42.5	16.4	0.6	44.6	6.9	6.6	3.5	5.9	1.2	10.1	3.3	1.6	4.3	0.9	5.9	0.9	7.7	16.7	3.7	21.3	0.7	3.6	15.4	33.7	19.8	15.8	24.2	17.3	18.2	16.3	16.3	24.8	19.5	17.1	18.1	8.3	22.1	21.7	30.8	18.9	25.0	38.5	66.3	41.0	63.2	39.0	81.3	34.8	27.2	32.8	10.1	14.9	3.5	0.9	1.0	1.4	2.3	0.2	2.5	36.1	1.2	3.5	0.0	1.9	3.3	1.8	21.4	0.3	1.4	0.0	1.0	1.6	2.7	1.2	2.3	2.1	1.8	3.2	0.0	0.6	5.0	39.0	2.3	3.5	11.8	1.0	1.4	0.5	0.4	1.4	2.8	5.0	0.9	6.5	0.8	34.5	18.8	3.4	1.3	1.5	1.4	0.4
CIDEA	CIDE-A	ENSG00000176194	"Cell death-inducing DFFA-like effector a"	O60543	18	12254319-12277595	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 79.9;breast: 32.6"	"Cell type enhanced"	"Detected in some"	15	"Late spermatids: 2.7;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"hTEC/SVTERT24-B: 5.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 12.2"							NA	NA						"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	79.9	1.5	0.1	5.8	1.7	0.2	32.6	0.0	1.9	1.1	8.0	0.0	0.6	0.2	0.2	0.2	2.1	0.2	4.9	2.4	0.2	0.0	0.2	0.3	0.2	0.3	0.1	1.5	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.5	0.0	2.1	0.3	1.0	3.0	0.8	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	3.4	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.9	0.2	0.0	0.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	0.0	0.4
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 705.0"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	145	"ASC diff: 282.1;RT4: 139.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced					NA	NA		30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	282.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	139.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0	32.8	75.0	1.5	0.4	12.8	0.2	16.2	0.0	40.2	48.9	0.0	0.0	0.3	0.0	0.1	0.9	172.1	0.0	0.0	4.6	0.6	7.6	0.4	25.6	0.0	120.8	0.0	0.0	12.9	57.0	0.6	1.4	13.8	15.1	1.0	0.0	0.7	0.1	0.0	1.1	0.0	1.7	705.0	59.7	0.0	0.1	12.2	0.6	0.0	0.0	61.1
FITM1	FIT1	ENSG00000139914	"Fat storage inducing transmembrane protein 1"	A5D6W6	14	24131275-24132849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 228.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	17	"RH-30: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA019842	Uncertain					NA	NA					"HPA019842: AB_1853025"	"unprognostic (1.81e-2)"	"unprognostic (4.29e-7)"	"unprognostic (2.77e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (1.00e-3)"	"unprognostic (1.20e-4)"	"unprognostic (4.57e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-3)"	0.8	1.7	0.0	0.2	0.0	0.6	0.3	0.4	0.2	0.2	0.3	0.0	0.0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0.0	0.0	0.2	13.1	0.2	0.3	0.0	0.0	0.2	11.9	0.2	0.2	0.2	0.0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0.0	2.5	0.3	0.3	0.0	0.0	0.5	79.9	3.6	0.3	0.0	0.8	0.3	0.0	1.1	0.4	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.6	0.1	0.0	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.0	0.3	0.2	27.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0.0	0.4	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.4	228.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	1.9	0.3	2.0	0.0	2.6	0.1	0.5	0.4	0.0	26.1	0.2	0.0	1.2	0.6	1.5	2.7	0.0	0.1	0.0	1.0	1.0	0.8	1.1	0.0	0.7	0.1	0.3	0.0	0.4	1.2	0.2	0.5	0.6	0.8	0.8	0.1
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302838-44311169	"Predicted membrane proteins"			"Deafness, Disease mutation, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 56.7"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	8.8	9.9	5.0	2.6	5.7	1.2	9.5	7.1	8.2	4.0	4.5	4.3	3.8	3.8	3.7	7.7	3.1	3.5	3.3	56.7	4.9	5.1	7.7	8.0	3.6	2.0	4.7	5.5	4.3	7.8	13.0	4.5	1.9	6.6	5.8	5.3	4.7	5.3	4.2	6.9	4.5	3.7	4.6	4.7	2.5	3.8	3.6	5.1	0.2	5.5	4.4	2.4	3.9	3.8	2.0	2.7	1.7	3.0	3.8	6.2	2.5	4.5	7.0	3.0	4.3	21.2	8.7	3.0	7.4	5.4	5.9	3.2	8.6	3.3	3.1	4.3	8.3	9.3	10.2	3.7	5.0	6.4	0.9	1.7	1.0	4.4	14.4	4.4	2.0	2.6	6.6	11.3	4.1	3.1	3.2	4.2	2.0	1.7	9.3	5.9	14.1	0.7	2.1	0.7	6.8	9.1	1.2	5.5	3.1	3.3	4.3	1.8	2.1	15.7	8.9	6.5	1.4	10.8	1.5	5.1	18.8	8.4	10.8	4.3	3.4	8.8	0.8	8.3	3.1	9.3	1.4	3.0	1.7	3.4	2.7	3.5	1.8	3.6	2.8	2.7	2.0	6.2	4.8	1.4	3.8	2.1	1.7	3.2	2.5	5.0	5.7	7.1	8.2	4.9	5.1	4.7	5.5	6.6	5.1	6.0	8.9	7.3	3.1	6.2	5.8	134.0	15.3	4.0	3.4	5.2	5.9	1.9	1.7	4.5	3.6	3.6	4.3	0.0	7.4	2.7	4.7	2.9	0.0	12.1	3.0	6.4	8.7	9.8	4.0	0.4	7.2	1.7	6.8	1.8	5.6	5.3	5.4	5.3	7.1	5.1	5.7	0.0	4.7	7.5	5.2	7.0	1.3	3.8	8.0	2.0
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 49.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	176	"ASC diff: 70.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		8900	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	70.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	49.1	0.0	0.0	0.0	1.8	1.3	4.9	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.4	0.2	0.4	0.0	0.0	0.0	0.7
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Cell type enhanced"	"Detected in many"	12	"Syncytiotrophoblasts: 1518.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Group enriched"	"Detected in many"	5	"ASC diff: 201.9;HHSteC: 174.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.3	2.4	201.9	27.5	36.6	9.3	7.2	5.7	6.5	4.4	0.6	0.0	0.1	19.0	36.6	0.3	3.2	0.0	9.8	11.8	0.0	15.5	0.4	16.5	174.9	1.8	28.4	29.1	3.3	13.9	0.0	4.6	7.0	0.0	2.8	3.4	22.0	0.8	4.2	6.3	4.4	0.0	5.7	10.2	1.5	0.1	0.0	10.8	0.2	5.4	4.3	1.1	9.1	4.4	2.2	4.1	11.0	0.0	1.7	8.8	0.0	2.0	2.0	6.2	0.0	3.1	0.9	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4	17.9	63.4	41.2	370.9	183.2	2.2	58.6	89.2	24.1	69.4	12.2	0.0	148.6	23.2	64.2	3.3	59.0	94.5	116.8	13.9	494.8	114.6	78.6	397.7	505.9	405.3	11.1	14.3	96.3	188.8	7.8	36.8	170.1	82.7	39.7	15.4	42.6	57.0	23.0	65.0	211.8	4.8	12.9	104.0	7.7	23.3	94.9	1518.0	59.8	29.9	214.1
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"		NA	Yes		9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	28.2	16.7	11.7	10.6	12.9	42.1	5.1	41.2	38.4	33.3	30.8	10.9	25.8	14.6	9.4	51.7	17.6	13.0	5.3	23.2	19.6	16.7	7.6	15.9	9.5	19.9	9.3	11.3	24.2	32.9	9.7	23.5	5.1	19.0	17.3	4.7	24.1	6.5	40.2	11.6	16.1	15.3	8.8	12.9	27.1	27.7	15.7	8.2	28.3	6.5	0.5	5.5	12.8	11.6	10.1	9.9	14.9	25.7	25.7	17.7	17.5	70.7	21.2	9.2	11.7	10.1	53.3	16.1	20.4	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1	17.9	24.6	17.5	48.4	126.4	0.2	2.5	10.2	64.3	42.1	10.4	2.0	124.8	31.5	90.9	8.1	25.3	190.9	0.0	74.9	62.3	89.7	37.6	54.3	14.4	92.9	0.0	39.0	29.4	63.2	9.8	33.1	85.3	52.3	65.9	60.5	22.6	161.7	98.2	49.8	32.3	0.6	51.8	50.5	46.1	15.6	200.5	162.9	17.5	40.8	62.6
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 31.3;Cholangiocytes: 10.2;Hepatocytes: 25.9;Ito cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 77.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		11000	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	77.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8	0.0	4.5	0.0	1.0	0.2	0.1	31.3	10.2	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	1.3	0.3	0.0	0.4	0.0	25.9	0.1	0.0	0.0	10.4	2.7	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.9	0.0	3.9	0.8	0.0	6.5	0.5	0.5	0.5	0.3	0.3	0.0	0.0	1.3
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	45.3	52.4	31.1	45.8	15.5	19.0	31.7	22.5	26.4	45.4	34.5	74.9	54.8	39.1	38.4	34.1	33.8	39.8	35.9	46.8	27.9	41.1	24.4	37.5	24.7	39.2	33.9	47.6	48.5	21.4	31.0	38.6	22.8	21.6	45.5	38.3	34.8	32.4	36.7	103.5	60.3	93.6	51.6	86.5	41.5	42.9	43.0	33.8	44.6	37.6	24.3	40.4	26.1	46.9	69.4	24.3	56.1	33.0	32.4	35.1	35.9	41.3	29.1	32.5	30.1	44.4	42.0	32.7	36.9	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4	71.5	93.0	166.0	108.0	88.8	35.0	7.9	117.2	41.5	46.6	82.0	9.8	320.7	180.8	238.7	1.8	77.3	292.4	23.3	272.4	398.0	69.2	127.9	107.3	102.4	338.5	41.3	93.0	87.2	194.1	5.3	45.5	157.2	129.9	390.5	160.1	42.9	250.4	210.5	26.9	236.5	23.6	97.0	60.9	13.0	106.5	106.3	357.3	222.6	164.6	168.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		7700000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	37.1	23.4	81.7	25.2	28.0	26.1	47.6	20.0	22.8	19.5	19.3	20.7	22.0	29.7	25.1	20.6	21.6	23.0	23.2	26.7	23.2	47.1	12.0	22.5	28.8	22.4	61.0	25.4	10.6	20.0	38.0	21.0	44.0	20.5	23.5	15.8	20.4	29.5	25.5	18.6	26.9	22.0	26.8	28.6	18.6	26.4	72.4	22.6	63.3	44.9	22.4	27.7	31.0	34.6	27.1	24.4	16.7	14.2	28.1	26.1	28.7	18.6	24.0	21.1	33.1	60.9	27.7	27.4	19.3	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4	86.4	80.7	105.5	134.5	437.2	53.8	298.4	104.4	129.8	72.8	294.8	25.5	104.9	207.2	242.7	375.6	106.2	128.9	163.5	183.3	167.5	182.4	291.0	146.3	81.8	104.3	154.1	271.6	108.6	144.9	304.1	182.1	233.4	318.9	92.8	133.9	100.9	238.2	181.4	283.9	113.6	53.2	620.9	265.8	57.5	61.8	400.4	328.6	110.8	99.3	394.6
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 486.0;Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		7600000			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	23.3	29.4	27.4	23.4	29.8	28.8	24.1	31.9	32.3	25.2	63.3	22.2	15.4	63.0	25.9	19.8	31.3	22.9	21.5	66.5	29.4	21.0	19.8	20.6	19.6	41.4	32.0	21.9	31.7	38.8	19.6	25.8	17.0	25.9	26.1	36.4	28.7	26.9	19.4	63.4	24.0	73.3	46.3	25.9	27.1	25.2	43.7	28.3	42.3	25.9	18.3	41.3	37.9	23.2	17.8	19.1	30.8	19.1	8.5	14.9	12.5	45.8	27.7	47.4	34.6	28.8	39.8	36.3	26.5	39.5	44.1	35.3	47.3	23.4	71.8	20.1	28.4	27.6	26.2	63.5	34.8	61.7	41.7	42.8	46.4	20.8	48.2	23.5	59.0	40.4	25.1	28.5	33.3	29.8	46.9	50.9	40.8	46.2	19.5	40.3	19.1	47.7	66.2	74.6	30.3	41.0	47.0	32.7	45.4	28.2	34.9	38.3	30.8	29.2	35.2	51.0	43.6	55.1	46.2	22.6	22.5	37.3	30.3	33.2	30.7	31.9	61.5	21.2	43.0	34.2	18.7	19.1	30.8	8.2	14.9	8.0	17.8	14.9	11.7	19.1	15.4	12.4	10.2	16.3	8.5	18.8	7.4	13.7	12.5	27.4	29.8	31.9	32.3	29.4	21.0	32.0	21.9	25.9	28.3	32.8	25.1	131.3	108.1	185.8	159.6	121.9	61.1	12.0	21.6	34.9	64.8	118.3	79.6	59.1	486.0	77.6	126.9	70.0	109.1	164.3	97.7	101.2	58.7	34.2	118.8	96.9	81.6	50.3	154.1	696.0	83.1	84.6	121.4	49.5	90.9	76.2	74.1	147.3	130.4	66.8	93.8	109.9	130.8	168.8	41.4	183.6	110.5	92.7	142.6	110.4
PRKACA	PKACa	ENSG00000072062	"Protein kinase cAMP-activated catalytic subunit alpha"	P17612	19	14091688-14118084	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 110.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010361, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1300000	Cytosol	"Cytokinetic bridge"	"CAB010361: AB_2268772, HPA071185: AB_2686356"	"unprognostic (1.08e-1)"	"prognostic favorable (6.28e-6)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.14e-3)"	25.6	43.4	19.6	17.8	22.7	9.1	34.1	29.1	39.6	20.6	17.5	16.0	16.2	13.4	19.8	15.6	20.9	18.8	16.4	91.6	20.7	29.4	14.7	34.5	16.5	28.2	21.6	27.5	47.0	15.6	20.8	24.6	15.4	26.9	16.6	16.2	18.4	15.5	24.9	92.4	13.4	14.4	29.0	16.2	28.1	13.9	24.4	11.1	15.2	15.7	26.2	14.8	21.1	17.3	1.7	2.4	8.6	5.3	0.7	1.7	1.2	26.2	15.3	34.7	41.3	30.7	32.7	6.3	28.0	25.9	39.8	36.5	18.6	9.4	11.4	22.7	44.3	19.4	17.2	24.4	26.5	37.8	20.7	12.3	20.9	28.9	18.0	26.3	12.9	22.2	31.1	12.8	31.6	11.0	24.6	33.5	18.7	19.6	29.8	40.6	38.9	29.0	9.7	12.4	26.6	34.1	26.2	32.0	26.3	19.4	16.7	27.4	17.5	25.3	15.5	11.5	17.5	22.1	12.5	25.9	47.0	13.1	62.9	26.1	20.6	21.1	16.8	31.5	19.6	17.6	0.3	3.4	0.4	1.7	5.3	0.8	1.7	0.9	1.1	2.4	1.3	1.2	1.7	8.6	0.7	4.6	1.6	0.8	1.2	19.6	22.7	29.1	39.6	20.7	29.4	21.6	27.5	26.9	11.1	6.0	4.3	11.5	6.1	7.8	40.4	110.4	28.1	4.0	2.3	14.0	25.5	5.8	6.6	10.7	25.7	21.6	16.0	0.0	16.2	4.8	14.3	7.3	0.0	30.1	29.0	3.2	16.8	31.9	44.8	12.8	45.5	32.4	13.5	7.2	14.3	24.1	13.5	7.0	48.8	9.6	23.0	19.4	17.3	25.7	6.4	9.8	6.8	7.2	11.4	6.4
PRKACB	PKACb	ENSG00000142875	"Protein kinase cAMP-activated catalytic subunit beta"	P22694	1	84078062-84238498	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010363, HPA029754, HPA071185"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA		1500000	Cytosol	"Cytokinetic bridge"	"CAB010363: AB_2170182, HPA029754: AB_10601491, HPA071185: AB_2686356"	"unprognostic (9.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.62e-2)"	"prognostic favorable (1.89e-6)"	"unprognostic (1.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.48e-1)"	7.0	21.5	40.0	10.5	57.0	6.2	8.0	54.7	85.5	9.4	23.6	16.9	3.9	4.8	8.7	17.6	8.1	5.2	11.5	10.1	43.1	52.1	10.6	9.0	6.9	16.2	38.3	33.5	8.3	11.9	12.2	18.3	5.1	35.5	13.8	22.6	4.9	32.9	12.7	3.2	2.6	6.3	12.6	47.7	14.6	14.2	3.6	25.9	25.5	11.1	1.8	15.3	13.5	4.6	13.5	7.1	17.1	5.4	25.9	27.6	22.0	3.1	6.3	10.1	12.1	11.7	10.3	4.7	15.6	11.9	8.0	7.5	0.1	2.8	16.6	10.8	12.2	14.6	2.2	4.7	5.1	8.5	16.1	2.6	36.5	8.6	1.2	11.5	14.4	0.8	6.1	2.3	7.7	4.3	11.6	36.6	6.2	1.1	9.6	12.9	0.6	18.7	7.6	9.9	0.0	4.4	14.5	15.7	10.0	19.4	11.2	3.3	12.9	8.6	3.3	9.5	7.9	3.0	3.0	32.4	11.1	8.6	11.2	11.8	7.1	8.5	16.7	5.3	15.4	13.8	17.1	2.7	5.8	23.3	3.6	18.7	13.5	17.3	20.6	7.1	10.2	26.4	27.6	1.5	25.9	5.4	4.1	15.9	22.0	40.0	57.0	54.7	58.2	43.1	52.1	38.3	33.5	35.5	25.9	0.0	1.0	20.3	6.7	4.5	44.0	38.9	15.3	4.0	5.7	14.0	33.4	1.4	28.2	6.9	2.4	8.4	61.7	0.0	10.3	1.0	11.0	15.2	57.7	14.8	23.2	44.5	20.8	26.4	52.7	2.6	13.8	32.7	15.1	1.0	61.1	36.9	13.3	28.8	20.5	15.6	30.0	12.9	13.7	5.9	6.9	2.5	0.6	69.2	52.4	6.5
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
